A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Myriad Genetics Inc stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 15,998 shares of MYGN stock, worth $219,812. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,998
Holding current value
$219,812
% of portfolio
0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$23.97 - $28.6 $383,472 - $457,542
15,998 New
15,998 $437,000
Q4 2023

Feb 14, 2024

BUY
$13.91 - $21.32 $62,595 - $95,940
4,500 Added 43.45%
14,856 $284,000
Q3 2023

Nov 15, 2023

SELL
$15.99 - $23.22 $548,824 - $796,980
-34,323 Reduced 76.82%
10,356 $166,000
Q2 2023

Aug 14, 2023

BUY
$17.56 - $23.76 $23,547 - $31,862
1,341 Added 3.09%
44,679 $1.04 Million
Q1 2023

May 15, 2023

BUY
$15.26 - $23.75 $82,602 - $128,558
5,413 Added 14.27%
43,338 $1.01 Million
Q4 2022

Feb 14, 2023

SELL
$14.51 - $20.99 $33,605 - $48,612
-2,316 Reduced 5.76%
37,925 $550,000
Q3 2022

Nov 14, 2022

BUY
$18.21 - $27.88 $56,833 - $87,013
3,121 Added 8.41%
40,241 $768,000
Q2 2022

Aug 15, 2022

SELL
$16.45 - $25.88 $76,508 - $120,367
-4,651 Reduced 11.13%
37,120 $674,000
Q1 2022

May 16, 2022

BUY
$22.67 - $28.01 $632,470 - $781,450
27,899 Added 201.12%
41,771 $1.05 Million
Q4 2021

Feb 14, 2022

BUY
$24.13 - $32.63 $334,731 - $452,643
13,872 New
13,872 $383,000
Q2 2021

Aug 16, 2021

SELL
$25.39 - $32.61 $1.42 Million - $1.82 Million
-55,845 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$19.92 - $31.6 $694,331 - $1.1 Million
-34,856 Reduced 38.43%
55,845 $1.7 Million
Q4 2020

Feb 16, 2021

BUY
$12.16 - $19.77 $440,605 - $716,346
36,234 Added 66.52%
90,701 $1.79 Million
Q3 2020

Nov 16, 2020

SELL
$11.25 - $14.75 $245,216 - $321,505
-21,797 Reduced 28.58%
54,467 $710,000
Q2 2020

Aug 14, 2020

BUY
$10.69 - $16.49 $815,262 - $1.26 Million
76,264 New
76,264 $865,000
Q3 2019

Nov 14, 2019

SELL
$22.08 - $47.08 $2.22 Million - $4.74 Million
-100,707 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$22.67 - $35.0 $221,123 - $341,390
-9,754 Reduced 8.83%
100,707 $2.8 Million
Q1 2019

May 15, 2019

BUY
$26.93 - $34.7 $925,099 - $1.19 Million
34,352 Added 45.14%
110,461 $3.67 Million
Q4 2018

Feb 14, 2019

BUY
$27.23 - $45.56 $569,760 - $953,297
20,924 Added 37.92%
76,109 $2.21 Million
Q3 2018

Nov 14, 2018

BUY
$37.57 - $50.34 $523,688 - $701,689
13,939 Added 33.79%
55,185 $2.54 Million
Q2 2018

Aug 14, 2018

BUY
$27.75 - $40.17 $678,182 - $981,714
24,439 Added 145.41%
41,246 $1.54 Million
Q1 2018

May 15, 2018

BUY
$28.83 - $41.01 $484,545 - $689,255
16,807 New
16,807 $497,000

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.11B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.